Literature DB >> 8579364

Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells.

C C Chao1, S H Park, A E Aust.   

Abstract

Treatment of human lung epithelial (A549) cells with crocidolite resulted in the formation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in the DNA, synthesis of mRNA for the inducible form of nitric oxide synthase (NOS), and increased intracellular nitrite (NO2-), a stable oxidation product of NO. Iron, associated with crocidolite, was involved in both NO2- and 8-OHdG formation. Addition of the NOS inhibitor, aminoguanidine (AG), reduced intracellular NO2- and prevented formation of 8-OHdG in crocidolite-treated cells, suggesting that NO was required in 8-OHdG formation. Addition of an NO-generating compound, diethyltriamine/NO, with AG and crocidolite resulted in recovery of 8-OHdG, further supporting a role for NO in oxidation of deoxyguanosine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8579364     DOI: 10.1006/abbi.1996.0059

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  27 in total

Review 1.  The molecular basis of asbestos induced lung injury.

Authors:  D W Kamp; S A Weitzman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

2.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.

Authors:  Günter Oberdörster; Andrew Maynard; Ken Donaldson; Vincent Castranova; Julie Fitzpatrick; Kevin Ausman; Janet Carter; Barbara Karn; Wolfgang Kreyling; David Lai; Stephen Olin; Nancy Monteiro-Riviere; David Warheit; Hong Yang
Journal:  Part Fibre Toxicol       Date:  2005-10-06       Impact factor: 9.400

Review 3.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 4.  Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Authors:  Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells.

Authors:  Timothy N Perkins; Paul M Peeters; Arti Shukla; Ingrid Arijs; Julie Dragon; Emiel F M Wouters; Niki L Reynaert; Brooke T Mossman
Journal:  Hum Mol Genet       Date:  2014-10-27       Impact factor: 6.150

6.  Mechanism of genotoxicity induced by targeted cytoplasmic irradiation.

Authors:  M Hong; A Xu; H Zhou; L Wu; G Randers-Pehrson; R M Santella; Z Yu; T K Hei
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

Review 7.  Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?

Authors:  Vanesa C Sanchez; Jodie R Pietruska; Nathan R Miselis; Robert H Hurt; Agnes B Kane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Sep-Oct

8.  Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat.

Authors:  S Tanaka; N Choe; D R Hemenway; S Zhu; S Matalon; E Kagan
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

Review 9.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

Review 10.  Role of endolysosome function in iron metabolism and brain carcinogenesis.

Authors:  Peter W Halcrow; Miranda L Lynch; Jonathan D Geiger; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2021-06-15       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.